de / en

PreventID® Influenza A plus B

PreventID® Influenza A plus B

Grippaler Infekt oder doch die echte Grippe?

Kleine Kinder, Schwangere, chronisch Kranke und ältere Menschen haben ein erhöhtes Risiko für Komplikationen bei einer „echten Grippe“, die durch eine Infektion mit Influenza-Viren hervorgerufen wird. Die Behandlung der Influenza sollte innerhalb der ersten 36 Stunden nach dem Auftreten der ersten Symptome beginnen. Daher ist eine schnelle Diagnosestellung entscheidend.

Container sizes

Number Article number PZN-Nummer
20 KST50112GP

Your advantages

  • Einfache Handhabung, schnelles Ergebnis, hohe Spezifität
  • Rasche Testung vor Therapiebeginn
  • In der Praxis, beim Hausbesuch, in Krankenhäusern oder in Pflegeeinrichtungen direkt durchführbar

Category

Tests for Doctors and Laboratories

Users

Professionals

Indications

Infection

Frequently asked questions

  • How does PreventID® Influenza A plus B work?

    PreventID® Influenza A plus B is a is a qualitative immunochemical rapid test which detects influenza A and B virus antigens quickly and safely in nose and throat swabs. The test can detect different influenza A subtypes, including H3N2 and H1N1.

  • Whom was this test developed for?

    PreventID® Influenza A plus B tests may only be conducted by health professionals. It is suitable for determining the presence of influenza A and B virus antigens in nose and throat swabs quickly and safely. The test can be performed at the doctor’s office, at the hospital, during home visits or at other care facilities, without great technical effort.

  • How long does the test take?

    About 12 minutes overall: 2 minutes to prepare, 10 minutes for the actual test.

  • How accurate is the test?

    In order to determine the relative clinical sensitivity and specificity, PreventID® Influenza A plus B was compared to RT-PCR. The relative RT-PCR sensitivity/specificity of PreventID® Influenza A plus B was 84.4% / 94.7% for type A strains, and 84.3% / 95.5% for type B strains. Furthermore, the test was compared to virus cultures (n=300): PreventID® Influenza A plus B achieved a sensitivity of 76% (114/150) and a specificity of 92% (238/150).

Salutation*

* Required fields

Write us